CEPI boosts 'Coronavirus X' vaccine search with expanded VBI Vaccines deal

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potentia...

December 8, 2022 | Thursday | News
Vaxxas raises A$34 M to clinically advance needle-free vaccines

Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...

December 6, 2022 | Tuesday | News
Australia takes aim at next pandemic threat with new vaccine platform

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, is to put $5.7 million (AU$8.5 million) into the...

November 28, 2022 | Monday | News
XtalPi, CK Life Sciences announce AI-empowered tumour vaccine R&D in China

Chinese firm XtalPi is embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group....

November 25, 2022 | Friday | News
IVI, ST Pharm exchange MoU on clinical development of COVID-19 vaccine

The International Vaccine Institute (IVI) and ST Pharm have exchanged a Memorandum of Understanding (MoU) to establish a...

November 25, 2022 | Friday | News
SK bioscience announces KRW 3 Bn donation to IVI to support advancement of global vaccine R&D

SK bioscience, a leading vaccine manufacturer based in the Republic of Korea and a key partner of the International Vacc...

November 18, 2022 | Friday | News
Australia offers new nasal vaccine strategy to improve COVID-19 protection

Researchers from the Centenary Institute and the University of Sydney in Australia have developed a new nasal vaccinatio...

November 17, 2022 | Thursday | News
Lemonex, IVI exchange MoU on joint vaccine development in Korea

The International Vaccine Institute (IVI), in South Korea, has signed a memorandum of understanding (MOU) with Lemonex, ...

November 14, 2022 | Monday | News
CSL signs $4 B agreement with Arcturus Therapeutics for self-amplifying mRNA vaccines

US-based Arcturus Therapeutics Holdings Inc. has announced a strategic collaboration with CSL Seqirus, a global vaccine ...

November 4, 2022 | Friday | News
Hilleman, MSD to develop thermostable next-gen Zaire ebolavirus vaccine

Singapore-based Hilleman Laboratories has announced collaberative efforts to develop a thermostable second-generati...

November 1, 2022 | Tuesday | News
CanSino Biologics rolls out inhaled vaccine Convidecia Air in Shanghai

CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...

November 1, 2022 | Tuesday | News
Who Needs Next Gen Vax Tech?

Globally, mass vaccination practices and procedures were not pleasant experiences for everyone. Different age groups and...

October 31, 2022 | Monday | Analysis
SK bioscience and Hilleman to co-develop novel vaccine platforms

South Korea's SK bioscience has entered a strategic partnership with Singapore based Hilleman Laboratories to co-develop...

October 27, 2022 | Thursday | News
SK bioscience gets $140 M from CEPI to develop mRNA vaccines

South Korea-based SK bioscience has made a new partnership agreement with Norway-based Coalition for Epidemic Preparedne...

October 26, 2022 | Wednesday | News
LimmaTech partners with Australia's Griffith University for world’s first vaccine against gonorrhoea

Swiss firm LimmaTech Biologics AG has announced a license and collaboration agreement with Griffith University...

October 25, 2022 | Tuesday | News
Etana unveils biopharmaceutical factory in Indonesia

PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...

October 20, 2022 | Thursday | News
Immuno Cure secures HK$8 M funding support for HIV vaccine clinical trial

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccin...

October 18, 2022 | Tuesday | News
EU recommends approval of Takeda's dengue vaccine

Japanese pharmaceutical firm Takeda has announced that the Committee for Medicinal Products for Human Use...

October 18, 2022 | Tuesday | News